A case of sleep apnea syndrome manifesting severe hypertension with high plasma norepinephrine levels

Endocrine Journal

Volumn 53, Issue 3, 2006, Pages 363-369

  Makino, Shinya ^a   Iwata, Masanobu ^a   Fujiwara, Masayoshi ^a   Ike, Shinpei ^a   Tateyama, Hitone ^a  

^a Osaka Gyomeikan Hospital   (Japan)

Author keywords

CPAP; Hypertension; Norepinephrine; Normetanephrine; Sleep apnea

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; DILTIAZEM; NORADRENALIN; NORMETADRENALIN; VANILMANDELIC ACID;

ADULT; ANAMNESIS; APNEA MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; HORMONE URINE LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; NORADRENALIN BLOOD LEVEL; NORADRENALIN URINE LEVEL; PATIENT COMPLIANCE; PHEOCHROMOCYTOMA; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; SCREENING TEST; SELF REPORT; SLEEP APNEA SYNDROME; SNORING; WEIGHT REDUCTION;

CONTINUOUS POSITIVE AIRWAY PRESSURE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTENSION; MIDDLE AGED; NOREPINEPHRINE; OBESITY; PHEOCHROMOCYTOMA; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE;

EID: 33745597868     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K05-169     Document Type: Article

References (37)

1. Lavie P, Herer P, Hoffstein V (2000) Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. Br Med J 320: 479-482.
2. Nieto FJ, Young TB, Ling BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, Pickering TG (2000) Association of sleepdisordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 283: 1829-1836.
3. Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep disordered breathing and hypertension. New Engl J Med 342: 1378-1384.
4. Faccenda JF, Mackay TW, Boon NA, Douglas NJ (2001) Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 163: 344-348.
5. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, Davies RJ (2002) Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359: 204-210.
6. Becker HF, Andreas Jerrentrup A, Ploch T, Psych D, Grote L, Penzel T, Sullivan CE, Herman Peter J (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107: 68-73.
7. Borgel J, Sanner BM, Keskin F, Bittlinsky A, Bartels NK, Buchner N, Huesing A, Rump LC, Mugge A (2004) Obstructive sleep apnea and blood pressure: interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs. Am J Hypertens 17: 1081-1087.
8. Ringler J, Basner RC, Shannon R, Schwartzstein R, Manning H, Weinberger SE, Weiss JW (1990) Hypoxemia alone does not explain blood pressure elevations after obstructive apneas. J Appl Physiol 69: 2143-2148.
9. Smith ML, Niedermaier ON, Hardy SM, Decker MJ, Strohl KP (1996) Role of hypoxemia in sleep apneainduced sympathoexcitation. J Auton Nerv Syst 56: 184-190.
10. Coy TV, Dimsdale JE, Israel SA, Clausen J (1996) Sleep apnea and sympathetic nervous system: a review. J Sleep Res 5: 42-50.
11. Dimsdale JE, Coy T, Ancoli-Israel S, Mills P, Clausen J, Ziegler MG (1997) Sympathetic nervous system alterations in sleep apnea. The relative importance of respiratory disturbance, hypoxia, and sleep quality. Chest 111: 639-642.
12. Elmasry A, Lindberg E, Hedner J, Janson C, Boman G (2002) Obstructive sleep apnoea and urinary catecholamines in hypertensive males: a population-based study. Eur Respir J 19: 511-517.
13. Roche F, Court-Fortune I, Pichot V, Duverney D, Costes F, Emonot A, Vergnon JM, Geyssant A, Lacour JR, Berthelemy JC (1999) Reduced cardiac sympathetic autonomic tone after long-term treatment with nasal continuous positive airways pressure in obstructive sleep apnoea syndrome. Clin Physiol 19: 127-134.
14. Nelesen R, Yu H, Ziegler M (2001) Continuous positive airways pressure normalises cardiac autonomic and hemodynamic responses to a laboratory stressor in apneic patients. Chest 119: 1092-1101.
15. Heitmann J, Ehlenz K, Penzel T, Becker HF, Grote L, Voigt KH, Herman Peter J, Vogelmeier C (2004) Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 23: 255-262.
16. Hoy LJ, Emery M, Wedzicha JA, Davison AG, Chew SL, Monson JP, Metcalfe KA (2004) Obstructive sleep apnea presenting as pseudopheochromocytoma: a case report. J Clin Endocrinol Metab 89: 2033-2038.
17. Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, Redline S, Henry JN, Getsy JE, Dinges DF (1993) Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 147: 887-895.
18. Scott BA, Gatenby R (1998) Imaging advances in the diagnosis of endocrine neoplasia. Curr Opin Oncol 10: 37-42.
19. Raber W, Raffesberg W, Bischof M, Scheuba C, Niederie B, Gasic S, Waldhausl W, Roden M (2000) Diagnostic effficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. Arch Intern Med 160: 2957-2963.
20. Lenders JWM, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G (2002) Biochemical diagnosis of pheochromocytoma. Which test is best? JAMA 287: 1427-1434.
21. Sawka AM, Jaschke R, Singh RJ, Young WF (2003) A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88: 553-558.
22. Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JWM, Keiser HR, Pacak K (2003) Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab 88: 2656-2666.
23. Lindsberg L, Young JB (1992) Pheochromocytoma. In: Wilson JD, Foster DW (eds) Williams Textbook of Endocrinology. WB Saunders, Philadelphia, 668-680.
24. Kvale WF, Roth GM, Manger WM, Priestley JT (1957) Present-day diagnosis and treatment of pheochromocytoma: a review of 51 cases. JAMA 164: 854-861.
25. Hume DM (1960) Pheochromocytoma in the adult and in the child. Am J Surg 99: 458-496.
26. Kirkendall WM, Liechty RD, Culp DA (1965) Diagnosis and treatment of patients with pheochromocytoma. Arch Intern Med 115: 529-536.
27. Lee RE, Rousseau P (1967) Pheochromocytoma and obesity. J Clin Endocrinol Metab 27: 1050-1052.
28. Baruzzi A, Riva R, Cirignotta F, Zucconi M, Cappelli M, Lugaresi E (1991) Atrial natriuretic peptide and catecholamines in obstructive sleep apnea sysndrome. Sleep 14: 83-86.
29. Minemura H, Akashiba T, Yamamoto H, Akahoshi T, Kosaka N, Horie T (1998) Acute effects of nasal continuous positive airway pressure on 24-hour blood pressure and catecholamines in patients with obstructive sleep apnea. Intern Med 37: 1009-1013.
30. Mayer J, Becker H, Brandenburg U, Penzel T, Peter JH, von Wichert P (1991) Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology 79: 84-92.
31. Hedner J, Darpo B, Ejnell H, Carlson J, Caidahl K (1995) Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J 8: 222-229.
32. Sanner BM, Tepel M, Markmann A, Zidek W (2002) Effect of continuous positive airway pressure therapy on 24-hour blood pressure in patients with obstructive sleep apnea syndrome. Am J Hypertens 15: 251-257.
33. Corry DB, Tuck ML (1999) Obesity, hypertension, and sympathetic nervous system activity. Curr Hypertens Rep 1: 119-126.
34. Esler M, Rumantir M, Wiesner G, Kaye D, Hastings J, Lambert G (2001) Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens 14: 304S-309S.
35. Sowers JR, Whitfield LA, Catania RA, Stern N, Tuck ML, Dornfeld L, Maxwell M (1982) Role of sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab 54: 1181-1186.
36. Tuck ML, Sowers JR, Dornfeld L, Whitfield LA, Maxwell M (1983) Reductions in plasma catecholamines and blood pressure during weight loss in obese subjects. Acta Endocrinol (Copenh) 102: 252-257.
37. Kushiro T, Kobayashi F, Osada H, Tomiyama H, Satoh K, Otsuka Y, Kurumatani H, Kajiwara N (1991) Role of sympathetic activity in blood pressure reduction with low calorie regimen. Hypertension 17: 965-968.